New Zealand Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: The national move to standardise community-access imaging is changing procurement priorities toward more modular CT/MRI capacity and community-grade monitoring kits. Te Whatu Ora’s Community Referred Radiology programme is rolling out national referral criteria that push diagnostic work into community settings, creating demand for portable imaging, cloud-enabled PACS connectors, and remote-monitoring devices that reduce central hospital burden (Sep-2025). Vendors that can deliver rapid installs, service SLAs and data integration win earlier adoption.

Industry Progression: A concrete market signal: Te Whatu Ora announced mandatory national CRR criteria that take effect from 01-Sep-2025, moving many outpatient imaging workflows into community hubs (Jul-2025 announcement). This policy accelerates procurements for community-friendly imaging and tied monitoring kits, shortening pilot timelines and creating scaled batch orders for vendors able to meet national interoperability and service requirements.

Industry Player Insights: Market playres influencing New Zealand include Fisher & Paykel Healthcare, ResMed, Philips Healthcare, and GE HealthCare etc. Domestic and regional suppliers are adapting: Fisher & Paykel’s FY-2024 organisational changes (Dec-2023) sharpened supply-chain focus and local support, while Philips and GE are pitching enterprise-to-community imaging bundles for CRR deployments (Sep-2025). These vendor moves populate New Zealand procurement pipelines with players able to combine clinical training, rapid deployment and ongoing device support.